{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:50:08Z","timestamp":1768567808910,"version":"3.49.0"},"posted":{"date-parts":[[2025,6,7]]},"group-title":"Neurology","reference-count":27,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T00:00:00Z","timestamp":1749254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,6,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Importance<\/jats:title>\n                  <jats:p>Medication adherence is widely emphasized in epilepsy management, with a belief that missing even single doses can trigger seizures. However, scientific evidence supporting this specific claim is limited, particularly regarding the impact of occasional missed doses rather than prolonged non-adherence.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To determine whether missing individual doses of anti-seizure medications (ASMs) increases short-term seizure risk in people with drug-resistant epilepsy.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Prospective cohort study conducted over 10 months for each participant, with data collected from March 2022 through January 2023. Analysis was performed in February 2023.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Community-based study with participants recruited via emails and online services.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Participants<\/jats:title>\n                  <jats:p>Adults with drug-resistant epilepsy experiencing 3 or more seizures per month, or adult caregivers of pediatric patients meeting these criteria. Participants used mobile applications to document both seizure occurrences and medication adherence.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Exposure<\/jats:title>\n                  <jats:p>Daily documentation of ASM doses, with missed doses categorized as 0 (no missed doses), 1 (one missed administration period), or 2 (two missed administration periods) per day.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Main Outcomes and Measures<\/jats:title>\n                  <jats:p>27 participants (median age 29) were followed. The relationship between seizure occurrence and missed ASM doses was assessed using mixed-effects logistic regression models, controlling for baseline seizure risk using a 90-day moving average (the \u201cNapkin method\u201d). Various time windows for missed doses and analyses accounting for medication half-lives were examined.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The Napkin method for seizure risk was significantly related to seizure occurrence (p&lt;0.001). However, missed ASM doses the day prior showed no significant relationship with seizure occurrence (p = 0.68). This lack of association persisted when examining longer time windows of missed doses and when accounting for medication half-lives. Sensitivity analyses demonstrated that the statistical approach could detect even small effects (5% increased seizure probability) of missed medication, confirming that the negative finding was less likely due to methodology.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions and Relevance<\/jats:title>\n                  <jats:p>While long-term medication non-adherence remains an important concern in epilepsy management, this study found no evidence that occasionally missing ASM doses significantly increases short-term seizure risk. These findings suggest that clinicians might reasonably reassure patients that infrequent missed doses may not dramatically impact immediate seizure likelihood, though consistent medication adherence should still be encouraged.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>KEY POINTS<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Question<\/jats:title>\n                    <jats:p>Does missing individual doses of anti-seizure medications significantly increase short-term seizure risk in people with drug-resistant epilepsy?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Findings<\/jats:title>\n                    <jats:p>In this 10-month prospective cohort study, the 90-day moving average of seizure frequency was significantly associated with seizure occurrence (p &lt; 0.001), but missed anti-seizure medication doses showed no significant association with seizure occurrence (p = 0.68), even when accounting for medication half-lives or examining different time windows.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Meaning<\/jats:title>\n                    <jats:p>While long-term medication adherence remains important in epilepsy management, occasionally missing doses may not significantly impact immediate seizure likelihood, which may help reduce unnecessary anxiety in patients who miss infrequent doses.<\/jats:p>\n                  <\/jats:sec>\n                <\/jats:sec>","DOI":"10.1101\/2025.06.06.25329144","type":"posted-content","created":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T20:45:12Z","timestamp":1749329112000},"source":"Crossref","is-referenced-by-count":0,"title":["Does missing medication acutely change seizure risk? A prospective study"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8370-2758","authenticated-orcid":false,"given":"Daniel M.","family":"Goldenholz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua C.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Moss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Brandon","family":"Westover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2025061000050935000_2025.06.06.25329144v1.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32596-0"},{"key":"2025061000050935000_2025.06.06.25329144v1.2","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12382"},{"key":"2025061000050935000_2025.06.06.25329144v1.3","doi-asserted-by":"crossref","unstructured":"Magdy R , Kishk NA , Fouad AM , Alsayyad E. Risk estimation of SUDEP during COVID-19 pandemic era in a tertiary referral center. Epilepsy Res 2021;173","DOI":"10.1016\/j.eplepsyres.2021.106625"},{"issue":"20","key":"2025061000050935000_2025.06.06.25329144v1.4","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1212\/01.wnl.0000319693.10338.b9","article-title":"Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study","volume":"71","year":"2008","journal-title":"[Internet]. Neurology"},{"key":"2025061000050935000_2025.06.06.25329144v1.5","doi-asserted-by":"crossref","first-page":"107052","DOI":"10.1016\/j.eplepsyres.2022.107052","article-title":"Exercise, medication adherence, and the menstrual cycle: How much do these change seizure risk? [Internet]","volume":"188","year":"2022","journal-title":"Epilepsy Res"},{"key":"2025061000050935000_2025.06.06.25329144v1.6","doi-asserted-by":"crossref","unstructured":"Goldenholz DM , Eccleston C , Moss R , Westover MB . Prospective validation of a seizure diary forecasting falls short [Internet]. Epilepsia 2024;[cited 2024 Apr 15] Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38606580\/","DOI":"10.1101\/2024.01.11.24301175"},{"key":"2025061000050935000_2025.06.06.25329144v1.7","doi-asserted-by":"crossref","first-page":"107474","DOI":"10.1016\/j.eplepsyres.2024.107474","article-title":"Necessary for seizure forecasting outcome metrics: Seizure frequency and benchmark model","volume":"208","year":"2024","journal-title":"Epilepsy Res"},{"key":"2025061000050935000_2025.06.06.25329144v1.8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/WCO.0000000000001344","article-title":"Seizure prediction and forecasting: a scoping review","volume":"38","year":"2025","journal-title":"Curr Opin Neurol"},{"key":"2025061000050935000_2025.06.06.25329144v1.9","doi-asserted-by":"crossref","first-page":"e208087","DOI":"10.1212\/WNL.0000000000208087","article-title":"Guidelines for Specialized Epilepsy Centers: Executive Summary of the Report of the National Association of Epilepsy Centers Guideline Panel","volume":"102","year":"2024","journal-title":"Neurology"},{"key":"2025061000050935000_2025.06.06.25329144v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.expneurol.2019.02.006"},{"key":"2025061000050935000_2025.06.06.25329144v1.11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-02974-x"},{"issue":"11","key":"2025061000050935000_2025.06.06.25329144v1.12","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S1474-4422(18)30274-6","article-title":"Circadian and circaseptan rhythms in human epilepsy: a retrospective cohort study","volume":"17","year":"2018","journal-title":"[Internet]. Lancet Neurol"},{"key":"2025061000050935000_2025.06.06.25329144v1.13","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/jep.12773","article-title":"Influence of the mode of administration on the results of medication adherence questionnaires","volume":"23","year":"2017","journal-title":"J Eval Clin Pract"},{"key":"2025061000050935000_2025.06.06.25329144v1.14","first-page":"E53","article-title":"Resistant hypertension: Detection, evaluation, and management a scientific statement from the American Heart Association","volume":"72","year":"2018","journal-title":"Hypertension"},{"issue":"3","key":"2025061000050935000_2025.06.06.25329144v1.15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1474-4422(18)30038-3","article-title":"Diagnostic challenges in epilepsy: seizure under-reporting and seizure detection","volume":"17","year":"2018","journal-title":"[Internet]. Lancet Neurol"},{"issue":"7","key":"2025061000050935000_2025.06.06.25329144v1.16","first-page":"e104","article-title":"How accurate do self-reported seizures need to be for effective medication management in epilepsy?","volume":"65","year":"2024","journal-title":"Epilepsia"},{"issue":"10","key":"2025061000050935000_2025.06.06.25329144v1.17","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1111\/epi.17730","article-title":"Quantifying and controlling the impact of regression to the mean on randomized controlled trials in epilepsy","volume":"64","year":"2023","journal-title":"[Internet]. Epilepsia"},{"issue":"2","key":"2025061000050935000_2025.06.06.25329144v1.18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/epi.17471","article-title":"Flexible realistic simulation of seizure occurrence recapitulating statistical properties of seizure diaries","volume":"64","year":"2023","journal-title":"[Internet]. Epilepsia"},{"key":"2025061000050935000_2025.06.06.25329144v1.19","doi-asserted-by":"crossref","unstructured":"Karoly P , Goldenholz DM , Cook M. Are the days of counting seizures numbered? Curr Opin Neurol 2018;31(2)","DOI":"10.1097\/WCO.0000000000000533"},{"issue":"12","key":"2025061000050935000_2025.06.06.25329144v1.20","first-page":"e128","article-title":"Comparing the efficacy, exposure, and cost of clinical trial analysis methods","volume":"60","year":"2019","journal-title":"[Internet]. Epilepsia"},{"key":"2025061000050935000_2025.06.06.25329144v1.21","doi-asserted-by":"crossref","unstructured":"Karoly PJ , Romero J , Cook MJ , et al. When can we trust responders? Serious concerns when using 50% response rate to assess clinical trials. Epilepsia 2019;60(9)","DOI":"10.1111\/epi.16321"},{"key":"2025061000050935000_2025.06.06.25329144v1.22","unstructured":"Chiang S , Vannucci M , Goldenholz D , et al. Variations in the natural history of epilepsy and epilepsy subgroups. [date unknown];5."},{"key":"2025061000050935000_2025.06.06.25329144v1.23","doi-asserted-by":"crossref","unstructured":"Goldenholz DM , Moss R , Scott J , et al. Confusing placebo effect with natural history in epilepsy: A big data approach. Ann Neurol 2015;78(3)","DOI":"10.1002\/ana.24470"},{"key":"2025061000050935000_2025.06.06.25329144v1.24","doi-asserted-by":"crossref","unstructured":"Goldenholz DM , Strashny A , Cook M , et al. A multi-dataset time-reversal approach to clinical trial placebo response and the relationship to natural variability in epilepsy. Seizure 2017;53","DOI":"10.1016\/j.seizure.2017.10.016"},{"key":"2025061000050935000_2025.06.06.25329144v1.25","doi-asserted-by":"crossref","unstructured":"Goldenholz DM , Goldenholz SR , Moss R , et al. Is seizure frequency variance a predictable quantity? Ann Clin Transl Neurol 2018;5(2)","DOI":"10.1002\/acn3.519"},{"issue":"3","key":"2025061000050935000_2025.06.06.25329144v1.26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/epi4.12237","article-title":"Characteristics of large patient-reported outcomes: Where can one million seizures get us? [Internet]","volume":"3","year":"2018","journal-title":"Epilepsia Open"},{"issue":"2","key":"2025061000050935000_2025.06.06.25329144v1.27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/epi4.12038","article-title":"Simulating clinical trials with and without intracranial EEG data","volume":"2","year":"2017","journal-title":"Epilepsia Open"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2025.06.06.25329144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:37:55Z","timestamp":1768509475000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2025.06.06.25329144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,7]]},"references-count":27,"URL":"https:\/\/doi.org\/10.1101\/2025.06.06.25329144","relation":{},"subject":[],"published":{"date-parts":[[2025,6,7]]},"subtype":"preprint"}}